Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Dusing R et al. – ACE inhibitor/ARB combinations showed equivocal effects on clinical outcomes. DRI/ACE inhibitor and DRI/ARB combinations reduced markers of organ damage, but longer–term trials are required to establish whether more complete renin––angiotensin––aldosterone system control with aliskiren–based therapy translates into improved outcome benefits.


Today in Dosing...keeping you current

Drug dosage protocol for calcium oxalate stone
Urological Research - Urolithiasis, 10/23/09

Telavancin: A Novel Lipoglycopeptide
Clinical Infectious Diseases, 11/16/09

Risperidone dose for schizophrenia
Cochrane Reviews, 10/21/09

Today in Drug Trials...keeping you current

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
New England Journal of Medicine, 11/20/09

Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest: A Randomized Trial
JAMA, 11/25/09

Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
Abbott, 11/16/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address